Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Intellia Therapeutics, Inc. securities between June 30, 2024 and January ...

Zacks Research decreased their Q1 2025 EPS estimates for CRISPR Therapeutics in a report issued on Wednesday, February 5th. Zacks Research analyst R. Department now anticipates that the company will ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

Scientists in Argentina have made history by creating the world's first genetically modified horses, designed to be faster ...

Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and complex class of genetic ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

For many years, cloned ponies have excelled in the prestigious equestrian sport of polo, and the sport has now taken a ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...